349 related articles for article (PubMed ID: 9924344)
1. Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa.
Fariss RN; Apte SS; Luthert PJ; Bird AC; Milam AH
Br J Ophthalmol; 1998 Nov; 82(11):1329-34. PubMed ID: 9924344
[TBL] [Abstract][Full Text] [Related]
2. TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy.
Chong NH; Alexander RA; Gin T; Bird AC; Luthert PJ
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):898-902. PubMed ID: 10711711
[TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of metalloproteinases-3 is a component of Bruch's membrane of the eye.
Fariss RN; Apte SS; Olsen BR; Iwata K; Milam AH
Am J Pathol; 1997 Jan; 150(1):323-8. PubMed ID: 9006347
[TBL] [Abstract][Full Text] [Related]
4. Sorsby fundus dystrophy - A review of pathology and disease mechanisms.
Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ
Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738
[TBL] [Abstract][Full Text] [Related]
5. Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane.
Majid MA; Smith VA; Matthews FJ; Newby AC; Dick AD
Br J Ophthalmol; 2006 Oct; 90(10):1310-5. PubMed ID: 16837541
[TBL] [Abstract][Full Text] [Related]
6. Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells.
Langton KP; McKie N; Smith BM; Brown NJ; Barker MD
Hum Mol Genet; 2005 Dec; 14(23):3579-86. PubMed ID: 16223891
[TBL] [Abstract][Full Text] [Related]
7. Peripapillary chorioretinal atrophy: Bruch's membrane changes and photoreceptor loss.
Curcio CA; Saunders PL; Younger PW; Malek G
Ophthalmology; 2000 Feb; 107(2):334-43. PubMed ID: 10690836
[TBL] [Abstract][Full Text] [Related]
8. Discrete expression and distribution pattern of TIMP-3 in the human retina and choroid.
Vranka JA; Johnson E; Zhu X; Shepardson A; Alexander JP; Bradley JM; Wirtz MK; Weleber RG; Klein ML; Acott TS
Curr Eye Res; 1997 Feb; 16(2):102-10. PubMed ID: 9068940
[TBL] [Abstract][Full Text] [Related]
9. TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration.
Kamei M; Hollyfield JG
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2367-75. PubMed ID: 10476804
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells.
Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
Br J Ophthalmol; 2002 Jan; 86(1):97-101. PubMed ID: 11801512
[TBL] [Abstract][Full Text] [Related]
11. Sorsby's fundus dystrophy tissue inhibitor of metalloproteinases-3 (TIMP-3) mutants have unimpaired matrix metalloproteinase inhibitory activities, but affect cell adhesion to the extracellular matrix.
Yeow KM; Kishnani NS; Hutton M; Hawkes SP; Murphy G; Edwards DR
Matrix Biol; 2002 Jan; 21(1):75-88. PubMed ID: 11827795
[TBL] [Abstract][Full Text] [Related]
12. Sorsby's fundus dystrophy: what does TIMP3 tell us about general mechanisms underlying macular degeneration?
Tymms MJ
Clin Exp Optom; 1999; 82(4):124-129. PubMed ID: 12482286
[TBL] [Abstract][Full Text] [Related]
13. Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase-3 induce apoptosis of retinal pigment epithelial and MCF-7 cells.
Majid MA; Smith VA; Easty DL; Baker AH; Newby AC
FEBS Lett; 2002 Oct; 529(2-3):281-5. PubMed ID: 12372614
[TBL] [Abstract][Full Text] [Related]
14. Sorsby fundus dystrophy: Insights from the past and looking to the future.
Anand-Apte B; Chao JR; Singh R; Stöhr H
J Neurosci Res; 2019 Jan; 97(1):88-97. PubMed ID: 30129971
[TBL] [Abstract][Full Text] [Related]
15. Expression of Sorsby's fundus dystrophy mutations in human retinal pigment epithelial cells reduces matrix metalloproteinase inhibition and may promote angiogenesis.
Qi JH; Ebrahem Q; Yeow K; Edwards DR; Fox PL; Anand-Apte B
J Biol Chem; 2002 Apr; 277(16):13394-400. PubMed ID: 11821400
[TBL] [Abstract][Full Text] [Related]
16. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3.
Majid MA; Smith VA; Newby AC; Dick AD
Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996
[TBL] [Abstract][Full Text] [Related]
17. Can Novel Treatment of Age-Related Macular Degeneration Be Developed by Better Understanding of Sorsby's Fundus Dystrophy.
Gourier HC; Chong NV
J Clin Med; 2015 May; 4(5):874-83. PubMed ID: 26239453
[TBL] [Abstract][Full Text] [Related]
18. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy.
Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ
J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594
[TBL] [Abstract][Full Text] [Related]
19. Measurement of TIMP-3 expression and Bruch's membrane thickness in human macula.
Bailey TA; Alexander RA; Dubovy SR; Luthert PJ; Chong NH
Exp Eye Res; 2001 Dec; 73(6):851-8. PubMed ID: 11846515
[TBL] [Abstract][Full Text] [Related]
20. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
Soboleva G; Geis B; Schrewe H; Weber BH
J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
